Public Policy

Trump's tariff policy: Abbott India, Ajanta Pharma to Alembic — pharma stocks crash up to 4%

· 24 July 2026 · 2 min read
Trump's tariff policy: Abbott India, Ajanta Pharma to Alembic — pharma stocks crash up to 4%

Mint has reported a new India-focused policy development: “Trump's tariff policy: Abbott India, Ajanta Pharma to Alembic — pharma stocks crash up to 4%.” The publisher's feed describes the story as follows: Pharma stocks dipped on July 24 after President Trump announced a phased tariff plan for imported generic medicines, raising concerns for Indian exporters. Abbott India led losses at 3.69%, prompting fears over the future of American production and long-term impacts on stocks. Intellectual

Original reporting by MintRead the full story

Intellectual Janata displays only original summaries of externally sourced news and links readers to the original publisher.

#policy#india#governance

Related reading

IJP
News Brief
The case for accountable lottery regulation in India
Public Policy·The Hindu·25 Sep 2026

The case for accountable lottery regulation in India

Read full story →
IJP
News Brief
Actis merges 11 India road assets into $1 billion trust
Public Policy·The Economic Times·25 Sep 2026

Actis merges 11 India road assets into $1 billion trust

Read full story →
IJP
News Brief
The murky world of political party finance
Public Policy·The Hindu·25 Sep 2026

The murky world of political party finance

Read full story →
IJP
News Brief
India’s growth outlook strengthens as economists see resilient incomes, stable policy: WEF
Public Policy·Mint·25 Sep 2026

India’s growth outlook strengthens as economists see resilient incomes, stable policy: WEF

Read full story →